Ropes & Gray Advises on Two of the Top Seven Biopharmaceutical Licensing Deals in 2024 Worth Up to $12.55 Billion
February 11, 2025
February 11, 2025
BOSTON, Massachusetts, Feb. 11 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advises on Two of the Top Seven Biopharmaceutical Licensing Deals in 2024 Worth Up to $12.55 Billion
Ropes & Gray represented clients in two of the top seven biopharmaceutical licensing deals measured by deal value in 2024, according to an analysis by GlobalData. Ropes & Gray attorneys advised clients in these top deals for an aggregate va . . .
* * *
Ropes & Gray Advises on Two of the Top Seven Biopharmaceutical Licensing Deals in 2024 Worth Up to $12.55 Billion
Ropes & Gray represented clients in two of the top seven biopharmaceutical licensing deals measured by deal value in 2024, according to an analysis by GlobalData. Ropes & Gray attorneys advised clients in these top deals for an aggregate va . . .